# Solaris Pharma Corp – FDA Inspection, Apr 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/b9f7b248-5c1f-4449-87fb-53f958ce2070
Source feed: FDA_Inspections

> FDA inspection 1317052 of Solaris Pharma Corp, April 21, 2026. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1317052
- Company Name: Solaris Pharma Corp
- Inspection Date: 2026-04-21
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 0

## Related Documents

- [FDA Inspection 1283114 - 2025-09-18](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/21c2d32d-4377-4be5-8382-b321a855a9ae)
- FDA Inspection 1117923 - 2020-01-09

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)

Company: https://www.keypedia.com/companies/solaris-pharma-corp/2730f83a-223f-4ef6-95e1-4e3b069342ce

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248